Analysis, cost-benefit evaluation

Each article was assessed for the type of evaluation and categorized (Table 1). Two factors were considered in determining the type of evaluation the presence of two or more alternatives, and the consideration of both input (costs) and outcomes. Evaluations that included two or more alternatives (i.e., concurrent control group, historical control, preintervention and postintervention design) were considered true analyses, whereas those that did not include a comparison were labeled descriptions. A description of the type of analysis was assigned to the evaluation and included the options of cost or outcome description, cost or outcome analysis, cost and outcome description, and true clinical economic evaluation. Those articles considered true clinical economic evaluations were subcategorized by type, options including cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis. 

It is not an easy task to answer the above questions because of the many uncertainties involved. There are some environmental accounting tools that could be employed in the evaluation process, such as life-cycle analysis, cost/benefit analysis, and contingent valuation method. ... 

Process Hazards Analysis. Analysis of processes for unrecogni2ed or inadequately controUed ha2ards (see Hazard analysis and risk assessment) is required by OSHA (36). The principal methods of analysis, in an approximate ascending order of intensity, are what-if checklist failure modes and effects ha2ard and operabiHty (HAZOP) and fault-tree analysis. Other complementary methods include human error prediction and cost/benefit analysis. The HAZOP method is the most popular as of 1995 because it can be used to identify ha2ards, pinpoint their causes and consequences, and disclose the need for protective systems. Fault-tree analysis is the method to be used if a quantitative evaluation of operational safety is needed to justify the implementation of process improvements. 

Subjective evaluation of recommendation effectiveness Subjective evaluation of recommendation effectiveness Cost/benefit analysis of recommendations... 

VI A - Value Impact Analysis, a form of cost benefit analysis that includes attribute evaluations in addition to dollars. 

Three evaluative modes are discussed here cost-benefit analysis, cost-effectiveness analysis (and its recently distinguished variant cost-consequences analysis) and cost-utility analysis. Books by Drummond et al (1997) and Gold et al (1996)—the two most respected and widely cited texts on health economics evaluations—give excellent accounts of these modes of economic evaluation, and interested readers are referred to them for more advanced discussions. 

Cost-benefit analysis (CBA) is unique among economic evaluations in that it addresses the extent to which a particular course of action, such as a drug treatment or a hospital admission, is economically or socially worth while in the broadest sense. A CBA measures... 

There are four types of economic evaluation cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. The analytic framework chosen will depend upon the economic questions posed and the clinical evidence of effectiveness for the interventions (Gold et al, 1996 Dmmmondetal, 1997). 

Important outcome indicators to evaluate postintoxication and/or postwithdrawal treatment of substance abuse and dependence can be divided into three major groups decreased consumption of substances, decreased problems associated with substance use, and increased psychosocial functioning. Although it is less commonly employed, a quality-of-life scale can help determine how substance abuse/dependence treatment has affected your patients lives. If you are involved in the cost-justification of services, a cost-benefit analysis could also become important, although this is more often used at the administrative level,... 

In many cases, various risk-reduction alternatives will result in a tolerable level of risk. Cost-benefit analysis can be a useful tool in evaluating alternative approaches. Costs are generally straightforward and easy to estimate however, estimating benefits may be more difficult, requiring assumptions that allow all benefits to be expressed using a common basis, usually monetary. 

In order to associate a number to represent the utility of these four outcomes we have to choose between several types of economic evaluations, basically between cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. The first of these is ruled out because it measures the health outcome in natural units. Given that the side effects of drags are of a varied nature, we need to be able to aggregate the different seriousness of these side effects in order to obtain a single utility, at least for the NSEA event. Furthermore, this utility must be comparable with that of, for example, the SER event. This is not possible with cost-effectivity. If we chose cost-utility, the utility associated with each event would be measured in QALYs gained or lost in each option. As QALYs are a universal measure of health benefit, cost-utility analysis could be appropriate for this type of decision. Lastly, cost-benefit analysis would also be appropriate, as it measures the utilities associated with each outcome in monetary terms, which reflect the willingness to pay for one of the outcomes in terms of safety and effectiveness. 

Table 12.1 summarizes five major types of pharmacoeconomic evaluations cost-consequence, cost-benefit, cost-effectiveness, cost-minimization, and cost-utility (Drummond et al., 1997 Kielhorn and Graf von der Schulenburg, 2000). In a cost-consequence analysis, a comprehensive list of relevant costs and outcomes (consequences) of alternative therapeutic approaches are presented in tabular form. Costs and outcomes are typically organized according to their relationship to cost (direct and indirect), quality of life, patient preferences, and clinical outcomes (see taxonomy below). No attempt is made to combine the costs and outcomes into an economic ratio, and the interpretation of the analysis is left in large part to the reader. 

Kuntz-Duriseti K (2004) Evaluating the economic value of the precautionary principle using cost benefit analysis to place a value on precaution. Environ Sci Policy 7 291-301 Lai R, Follett RF, Kimble J, Cole CV (1999) Managing US cropland to sequester carbon in soil. 

Both qualitative and quantitative evaluation techniques may be used to consider the risk associated with a facility. The level and magnitude of these reviews should be commensurate with the risk that the facility represents. High value, critical facilities or employee vulnerability may warrant high review levels. While unmanned "off-the-shelf, low hazard facilities may suffice with only a checklist review. Specialized studies are performed when in-depth analysis is needed to determine the cost benefit of a safety feature or to fully demonstrate the intended safety feature has the capability to fully meet prescribed safety requirements. 

Methodically devised and established methods (and criteria) of substance and process assessment and evaluation like risk analysis, toxicological and ecotoxi-cological analyses, life-cycle-analysis and cost-benefit analysis . But also much simpler approaches, which in practice play an important role for assessing formulations and snbstance properties (e.g. the nse of negative and/or positive lists). 

Economic evaluation compares costs and consequences of alternative health care treatments or programs (Drummond et al. 2005). In one form of economic evaluation, cost-benefit analysis, all costs and consequences are valued in monetary terms. However, in health care it is much more common to use cost-effectiveness analysis, where the difference in cost between alternatives is compared with the difference in outcomes measured in units such as life years gained or quality-adjusted life years (QALYs) gained. 

The methods of cost-benefit analysis may be applied to evaluate the total costs and benefits of interventions that are being compared by analyzing their cost-benefit ratios or their net benefits. Furthermore, the additional or incremental cost of an intervention (i.e., the difference in cost between a new... 

In summary, economic analysis of medical technology or medical care evaluates a medical service by comparing its monetary cost with its monetary benefit (cost-benefit), by measuring its monetary cost in relation to its outcomes (cost-effectiveness), or simply by tabulating the costs involved (cost-identification). Direct costs are generated as services are provided. In addition, productivity costs should be considered, especially in determining the benefit of a service that decreases morbidity or mortality. Finally, the perspective of the study determines the costs and benefits that will be quantified in the analysis, and sensitivity analyses test the effects of changes in variable specifications for estimated measures on the results of the study. 

Define the unit of payment, which is directly related to the functions performed by a chemical, e.g. metal pieces degreased, m3 water cleaned. Carry out a detailed cost benefit analysis (CBA) to evaluate the expected environmental and economic savings of the ChL business model. 

Environmental Impact Assessment (EIA) has evolved as a comprehensive approach to project evaluation, in which environmental factors, as well as economic and technical considerations (e.g. Cost Benefit Analysis), are given appropriate consideration in the decisionmaking process. The purpose of an EIA study is to determine the potential environmental, social and health effects of a proposed development. It attempts to define and assess the physical, biological and socio-economic effects, so that logical and rational decisions are made. The identification of possible alternative sites and/or processes may assist in the reduction of potential adverse impacts. 

---